The 10-second takeaway
For the quarter ended March 31 (Q4), Abaxis beat expectations on revenues and beat expectations on earnings per share.
Compared with the prior-year quarter, revenue expanded and GAAP earnings per share improved significantly.
Margins grew across the board.
Abaxis recorded revenue of $42.7 million. The nine analysts polled by S&P Capital IQ expected to see revenue of $40.7 million on the same basis. GAAP reported sales were 14% higher than the prior-year quarter's $37.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.21. The nine earnings estimates compiled by S&P Capital IQ forecast $0.16 per share. GAAP EPS of $0.21 for Q4 were 40% higher than the prior-year quarter's $0.15 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 54.7%, 20 basis points better than the prior-year quarter. Operating margin was 15.1%, 100 basis points better than the prior-year quarter. Net margin was 11.0%, 200 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $40.7 million. On the bottom line, the average EPS estimate is $0.17.
Next year's average estimate for revenue is $177.0 million. The average EPS estimate is $0.86.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 160 members out of 177 rating the stock outperform, and 17 members rating it underperform. Among 45 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 43 give Abaxis a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Abaxis is outperform, with an average price target of $31.66.
Over the decades, small-cap stocks like Abaxis have provided market-beating returns, provided they're value-priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Get instant access to this free report.
- Add Abaxis to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings. He is the co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
This Company's "Dismal" Performance Masks Excellent Opportunity
This company may be undervalued by the market.
Why Abaxis Shares Sank
Is this meaningful? Or just another movement?
Amarin, Cubist Pharmaceuticals, and Abaxis Could Be Big Movers Today
Keep an eye on Amarin, Cubist, and Abaxis -- they could make big moves during today's trading.